Wang Chunling, Wang Yijin
School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Antioxid Redox Signal. 2023 Mar;38(7-9):529-549. doi: 10.1089/ars.2022.0114. Epub 2023 Feb 28.
Liver disease is one of the biggest threats to public health, affecting as much as 5.5 million people worldwide. Mitochondrial dysfunction is associated with various acute and chronic liver diseases. Mitophagy, a selective form of autophagy for damaged/excessive mitochondria, plays a key role either in the pathogenesis or in maintaining hepatic homeostasis in response to various liver diseases. Significant progress has been achieved to ascertain the causes of liver disease. The conserved pathways for mitochondrial degradation mitophagy, the deregulation of mitophagy in liver diseases, and pharmacological or genetic maneuvers that alter the mitophagic flux for liver disease treatment have been widely studied but yet to be comprehensively reviewed. Liver disease is considered a leading cause of mortality globally, causing the heavy burden of disability and the increased health care utilization that needs to be settled urgently. Mitophagy plays an important role in protecting liver from tissue damage to maintain hepatic homeostasis or in pathogenesis of liver disease. Elaborating mitophagy implicated in the pathogenesis of liver disease, as well as potential therapeutic regimens by targeting mitophagy is of great significance for the understanding and treatment of liver disease. This review comprehensively describes the distinct mitophagy signaling pathways and their interplay with various liver diseases. Given that mitophagy affects a wide array of physiological processes, a deeper understanding of how to modulate mitophagy could provide innovative avenues for precise therapy. Future studies based on pharmacologically or genetically targeting mitophagy-relevant factors will uncover the links between intact mitophagic responses and hepatic homeostasis in physiological and pathological settings. This will allow us to overcome obstacles of applying mitophagy as the therapeutic target in the clinic. 38, 529-549.
肝脏疾病是对公众健康的最大威胁之一,全球多达550万人受其影响。线粒体功能障碍与各种急慢性肝脏疾病相关。线粒体自噬是一种针对受损/过量线粒体的选择性自噬形式,在各种肝脏疾病的发病机制或维持肝脏内环境稳定中起关键作用。在确定肝脏疾病病因方面已取得重大进展。线粒体降解的保守途径——线粒体自噬、肝脏疾病中线粒体自噬的失调,以及改变线粒体自噬通量用于肝脏疾病治疗的药理学或遗传学策略已得到广泛研究,但尚未进行全面综述。肝脏疾病被认为是全球主要的死亡原因,导致沉重的残疾负担和医疗保健利用率增加,亟待解决。线粒体自噬在保护肝脏免受组织损伤以维持肝脏内环境稳定或在肝脏疾病的发病机制中起重要作用。阐述与肝脏疾病发病机制相关的线粒体自噬以及通过靶向线粒体自噬的潜在治疗方案对于肝脏疾病的理解和治疗具有重要意义。本综述全面描述了不同的线粒体自噬信号通路及其与各种肝脏疾病的相互作用。鉴于线粒体自噬影响广泛的生理过程,更深入地了解如何调节线粒体自噬可为精准治疗提供创新途径。基于药理学或遗传学靶向线粒体自噬相关因子的未来研究将揭示生理和病理环境中完整的线粒体自噬反应与肝脏内环境稳定之间的联系。这将使我们能够克服将线粒体自噬作为临床治疗靶点应用时的障碍。38, 529 - 549。